Schwartz Carl I. 4

4 · Predictive Oncology Inc. · Filed Sep 9, 2020

Form 4

Period: 2020-09-04

10% Owner

Transactions

Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−20,000→ 0 total
Exercise: $7.48Exp: 2029-04-04→ Common Stock (20,000 underlying)
Award
Stock Options (Right to buy)
2020-09-04+20,000→ 20,000 total
Exercise: $1.54Exp: 2029-04-04→ Common Stock (20,000 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−4,219→ 0 total
Exercise: $7.90Exp: 2029-07-01→ Common Stock (4,219 underlying)
Award
Stock Options (Right to buy)
2020-09-04+4,219→ 4,219 total
Exercise: $1.54Exp: 2029-07-01→ Common Stock (4,219 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−5,128→ 0 total
Exercise: $6.50Exp: 2029-08-01→ Common Stock (5,128 underlying)
Award
Stock Options (Right to buy)
2020-09-04+5,128→ 5,128 total
Exercise: $1.54Exp: 2029-08-01→ Common Stock (5,128 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−6,050→ 0 total
Exercise: $5.51Exp: 2029-09-01→ Common Stock (6,050 underlying)
Award
Stock Options (Right to buy)
2020-09-04+6,050→ 6,050 total
Exercise: $1.54Exp: 2029-09-01→ Common Stock (6,050 underlying)

Holdings

Footnotes (4)

[F1]All transactions reported on this form involve the repricing of stock options with an exercise price greater than $1.54 to an exercise price of $1.54, as approved by shareholders at the 2020 annual meeting, with certification of the shareholder vote as of September 4, 2020.
[F2]Currently exercisable.
[F3]Held by the Carl I. Schwartz Revocable Living Trust
[F4]15,000 shares are currently vested; 2,500 shares vest on each of 10/4/2020 and 1/4/2021.

Documents

1 file